Literature DB >> 27038696

Neutrophil-to-lymphocyte ratio as a detection marker of tumor recurrence in patients with muscle-invasive bladder cancer after radical cystectomy.

Yosuke Morizawa1, Makito Miyake1, Keiji Shimada2, Shunta Hori1, Yoshihiro Tatsumi3, Yasushi Nakai1, Satoshi Anai1, Nobumichi Tanaka1, Noboru Konishi2, Kiyohide Fujimoto4.   

Abstract

PURPOSE: High-neutrophil to lymphocyte ratio (NLR) values have been shown to be associated with a poor prognosis in many human malignant tumors. We evaluated the correlation of the NLR with other variables in patients with muscle-invasive bladder cancer after radical cystectomy (RC); in particular, we evaluated chronological changes in the postoperative NLR.
METHODS: We included the data from a total of 110 patients who underwent RC for muscle-invasive bladder cancer. The NLR was calculated using complete blood counts determined before RC. Kaplan-Meier and Cox proportional regression analyses of recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS) were performed to identify significant prognostic variables.
RESULTS: The median patient age was 72 years (41-91 years). In univariate analysis, the pretreatment NLR (≥2.6 vs.<2.6) was associated with RFS (hazard ratio [HR] = 2.41, P = 0.008), CSS (HR = 2.89, P = 0.006), and OS (HR = 2.73, P = 0.002). In multivariate analysis, an NLR≥2.6 and an infiltrative growth pattern at the tumor invasion front were significantly associated with RFS (HR = 2.61, P = 0.023), CSS (HR = 2.58, P = 0.08), and OS (HR = 2.77, P = 0.004). Postoperative chronological analysis revealed that the NLR of 68 patients without recurrence remained low during follow-up, whereas the NLR of the remaining 42 patients with recurrence increased significantly in the last visit before recurrence was detected radiographically (P< 0.01).
CONCLUSIONS: The NLR and tumor growth pattern were strong predictors of prognosis for patients undergoing RC. Our results suggest that an increase in the NLR during follow-up after RC is a potential marker for the early detection of recurrence.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Muscle-invasive bladder cancer; NLR; Recurrence; Tumor growth pattern

Mesh:

Year:  2016        PMID: 27038696     DOI: 10.1016/j.urolonc.2016.02.012

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  26 in total

1.  The prognostic role of preoperative circulating neutrophil-lymphocyte ratio in primary bladder cancer patients undergoing radical cystectomy: a meta-analysis.

Authors:  Guoming Hu; Feng Xu; Kefang Zhong; Shimin Wang; Qi Xu; Liming Huang; Pu Cheng
Journal:  World J Urol       Date:  2018-12-03       Impact factor: 4.226

2.  The clinical use of neutrophil-to-lymphocyte ratio in bladder cancer patients: a systematic review and meta-analysis.

Authors:  Xingxing Tang; Peng Du; Yong Yang
Journal:  Int J Clin Oncol       Date:  2017-07-27       Impact factor: 3.402

3.  High postoperative neutrophil-to-lymphocyte ratio as a poor prognostic marker in patients with upper tract urothelial carcinoma.

Authors:  Kiyoaki Nishihara; Shigetaka Suekane; Kousuke Ueda; Makoto Nakiri; Mitsunori Matsuo; Tsukasa Igawa
Journal:  Oncol Lett       Date:  2019-03-21       Impact factor: 2.967

4.  The predictive role of preoperative and postoperative neutrophil-lymphocyte ratio in sarcomatoid renal cell carcinoma.

Authors:  Roy Mano; Jessica Flynn; Kyle A Blum; Andrew W Silagy; Renzo G DiNatale; Julian Marcon; Alan Wang; Alejandro Sanchez; Jonathan A Coleman; Paul Russo; Irina Ostrovnaya; A Ari Hakimi
Journal:  Urol Oncol       Date:  2019-10-04       Impact factor: 3.498

5.  Diagnostic and prognostic role of urinary collagens in primary human bladder cancer.

Authors:  Makito Miyake; Yosuke Morizawa; Shunta Hori; Yoshihiro Tatsumi; Sayuri Onishi; Takuya Owari; Kota Iida; Kenta Onishi; Daisuke Gotoh; Yasushi Nakai; Satoshi Anai; Yoshitomo Chihara; Kazumasa Torimoto; Katsuya Aoki; Nobumichi Tanaka; Keiji Shimada; Noboru Konishi; Kiyohide Fujimoto
Journal:  Cancer Sci       Date:  2017-09-15       Impact factor: 6.716

6.  Prognostic value of neutrophil-to-lymphocyte ratio in urothelial carcinoma of the upper urinary tract and bladder: a systematic review and meta-analysis.

Authors:  Xintao Li; Xin Ma; Lu Tang; Baojun Wang; Luyao Chen; Fan Zhang; Xu Zhang
Journal:  Oncotarget       Date:  2016-04-27

7.  Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha 1 (COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladder.

Authors:  Makito Miyake; Shunta Hori; Yosuke Morizawa; Yoshihiro Tatsumi; Michihiro Toritsuka; Sayuri Ohnishi; Keiji Shimada; Hideki Furuya; Vedbar S Khadka; Youping Deng; Kenta Ohnishi; Kota Iida; Daisuke Gotoh; Yasushi Nakai; Takeshi Inoue; Satoshi Anai; Kazumasa Torimoto; Katsuya Aoki; Nobumichi Tanaka; Noboru Konishi; Kiyohide Fujimoto
Journal:  Oncotarget       Date:  2017-05-30

8.  Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.

Authors:  Minyong Kang; Chang Wook Jeong; Cheol Kwak; Hyeon Hoe Kim; Ja Hyeon Ku
Journal:  Oncotarget       Date:  2017-02-21

9.  Predictive role of neutrophil-to-lymphocyte ratio on upstaging of organ-confined invasive urothelial bladder cancer to non-organ-confined disease.

Authors:  Ertuğrul Şefik; Bülent Günlüsoy; Özgü Aydoğdu; Yusuf Kadir Topçu; Yasin Ceylan; Tansu Değirmenci; Çetin Dinçel
Journal:  Turk J Urol       Date:  2018-03-01

10.  The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis.

Authors:  Ross D Dolan; Jason Lim; Stephen T McSorley; Paul G Horgan; Donald C McMillan
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.